Chris Christie suggests that Trump might reclassify cannabis, fueling investor optimism and boosting stocks in hopes of federal reform and market expansion.
From Colorado's cannabis paradox to Puerto Rico’s promising growth, plus the surge in demand for psychedelics therapy and Germany’s shifting policy landscape.
From veterans turning to psychedelics for PTSD to cannabis stocks reeling post-election and Puerto Rico’s promising market expansion, here’s what you need to know.
RFK Jr. shakes up the health agenda, Red Mesa cuts costs, and Jaunty redefines the game—insights and strategies you need this weekend.
Earnings flood reveals highs and lows in cannabis—top players tackle market hurdles, bold moves, and potential rebounds.
From Florida’s halt to Dallas’s green light, here’s where cannabis reform stands after last night’s votes.
As America votes, cannabis faces pivotal choices: from Florida hemp donors backing anti-weed stance and DEA hearings to shifting profit margins, here’s what’s at stake for the industry.
Election Day, big earnings, and regulatory moves—today’s updates cover how votes, revenue reports, and policy shifts could shape cannabis. Get ready!
Cannabis rescheduling, election jitters, and Florida's legalization ad battle—plus insights into workplace cannabis use, loyalty trends, and psychedelics for PTSD.
NYC cannabis crackdown on illicit cannabis shops hits a legal snag, AZ rolls out delivery early, and Uruguay leads with regulated markets.
New licenses spark fresh opportunities, while evolving voter polls and policy changes set the stage for cannabis markets to bloom across borders.
Cannabis votes in Florida, Nebraska, and North Dakota could redefine state laws. Plus, a THC pizza mix-up in Wisconsin and a caffeine-THC ban heats up in New York.
